Showing 5321-5330 of 20465 results for "".
- Adenotonsillectomy Enhances Sleep and Respiratory Health in Children with OSAhttps://reachmd.com/news/adenotonsillectomy-enhances-sleep-and-respiratory-health-in-children-with-osa/2484279/According to a new study published in The Laryngoscope, adenotonsillectomy produces substantial improvements in children with obstructive sleep apnea. In a cohort o
- Understanding HIV Persistence: The Role of Perineural Pathwayshttps://reachmd.com/news/understanding-hiv-persistence-the-role-of-perineural-pathways/2484273/New primate data suggest CNS macrophages can carry HIV out of the brain along a perineural route, driving peripheral viral persistence and inflammation despite suppressiv
- LiPyDau: A Promising Preclinical Agent in Cancer Therapyhttps://reachmd.com/news/lipydau-a-promising-preclinical-agent-in-cancer-therapy/2484265/According to a new article in Molecular Cancer, LiPyDau appears to create persistent DNA lesions consistent with irreversible crosslinking, generat
- Prenatal COVID-19 Exposure: Assessing Risks for Neurodevelopmental Disordershttps://reachmd.com/news/prenatal-covid-19-exposure-assessing-risks-for-neurodevelopmental-disorders/2484268/A Mass General Brigham analysis found prenatal SARS‑CoV‑2 exposure was associated with an increased ri
- Pediatric AD: Tapinarof Cream 1% Delivers Clear Skin and Reduced Burdenhttps://reachmd.com/news/pediatric-ad-tapinarof-cream-1-delivers-clear-skin-and-reduced-burden/2484254/In the pivotal ADORING 1 and 2 phase 3 trials, tapinarof cream 1% (VTAMA, Organon) showed consistent and statistically significant efficacy across all pediatric age groups in children with atopic dermatitis (AD), with benefits extending to sleep and family impact o
- Early-Life Stress: A Risk Factor for Developing Psoriasishttps://reachmd.com/news/early-life-stress-a-risk-factor-for-developing-psoriasis/2484258/According to a Swedish birth‑cohort analysis, changes in family structure during infancy were associated with an al
- Enhancing Diagnosis of Adenoviral Conjunctivitis: Silver-Amplified Lateral Flow Kits in Focushttps://reachmd.com/news/enhancing-diagnosis-of-adenoviral-conjunctivitis-silver-amplified-lateral-flow-kits-in-focus/2484248/A recent multicenter prospective study in Viruses shows that silver‑amplified lateral flow kits substantially improve point‑of‑care detection of adenoviral conjunctivitis, with sensitivity 86.0
- Tapinarof Sustains AD Remission for 75+ Days Post-Treatmenthttps://reachmd.com/news/tapinarof-sustains-ad-remission-for-75-days-post-treatment/2484253/New long-term data from the ADORING 3 trial show that tapinarof cream 1% (VTAMA, Organon), a non-steroidal topical aryl hydrocarbon receptor agonist, can sustain low disease activity and pruritus in patients with atopic dermatitis (AD), including children as young
- Topical Caffeine May Provide Hair Growth Benefit for Alopecia: Studyhttps://reachmd.com/news/topical-caffeine-may-provide-hair-growth-benefit-for-alopecia-study/2484243/Topical caffeine may be a promising adjunct treatment for hair loss, according to a systematic review published in the Journal of Drugs in Dermatology. The analysis assessed original studies investigating caffeine’s effects on hair growth across multiple fo
- Advancing Neurodegenerative Diagnostics: The Role of TDP-43 PET Tracer ACI-19626https://reachmd.com/news/advancing-neurodegenerative-diagnostics-the-role-of-tdp-43-pet-tracer-aci-19626/2484108/AC Immune has introduced ACI-19626, a first-in-class TDP-43 PET tracer that could change diagnosis and trial design by enabling in vivo imaging of aggregated TDP‑43 in neurodegenerative disease. The company reports preclinical characterization published alongside a N